Demetra and Masmec Biomed Forge Strategic Partnership in Medical Technology

Demetra Holding and Masmec Biomed Enter Strategic Alliance to Advance Medical Technology.

MILAN, July 22, 2026 – Demetra Holding has announced a strategic collaboration with Masmec Biomed, an Italian company specializing in the development of advanced surgical navigation systems, artificial intelligence, and high-complexity medical technologies.

The partnership leverages the complementary strengths of both organizations. Demetra brings solid expertise in orthopedics, spine, and neurology, international presence, and deep market understanding. Masmec contributes advanced capabilities in biomedical engineering, surgical navigation, and AI, laying the groundwork to accelerate the adoption of increasingly sophisticated solutions for surgeons, healthcare facilities, and patients.

"Demetra's story began in the operating rooms, alongside surgeons. It is there we continue to seek and understand the future. A new generation of emerging technologies will make surgery more precise, predictive, and increasingly personalized. This transformation requires a new industrial model, capable of connecting clinical expertise, artificial intelligence, navigation, robotics, and data," said Michele Perrino, CEO of Demetra Holding.

The collaboration reinforces the conviction that the future will be driven not only by new implants, materials, or surgical techniques, but by the ability to integrate clinical knowledge, data, software, AI, and advanced technologies into an ecosystem that can improve every phase of the care process. Demetra aims to solidify its position as a European platform for clinical and technological innovation, identifying, connecting, and empowering the sector's best expertise while accelerating the adoption of advanced solutions.

"The most relevant companies of the next decade will not be those that simply produce better technologies, but those capable of creating ecosystems where innovation, knowledge, and experience work together to generate value. This is the future we are building: not a single product, but the creation of a new generation of solutions for surgery," Perrino concluded.